Speech-Language Pathologists in Spotswood, NJ Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Amanda Gagnon, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 441 Manalapan Rd, Spotswood, NJ 08884 Phone: 908-616-4770 |
News Archive
Interactive weight management website program helps weight loss maintenance
The more people used an interactive weight management website, the more weight loss they maintained, according to a Kaiser Permanente Center for Health Research study published online today in the Journal of Medical Internet Research.The National Institutes of Health-funded study evaluated an Internet-based weight maintenance intervention involving 348 participants. Consistent website users who logged on and recorded their weight at least once a month for two-and-a-half years maintained the most weight loss, the study found.
Johns Hopkins researchers to present latest findings on TB and HIV at CROI 2019
Johns Hopkins Medicine researchers are attending the annual Conference on Retroviruses and Opportunistic Infections, where they are sharing their latest findings in the ongoing battle against HIV/AIDS and related infectious diseases with other top basic, translational and clinical researchers from around the world.
Study reveals surprising relationships between diet and release of hormones that suppress eating
By comparing how gut microbes from human vegetarians and grass-grazing baboons digest different diets, researchers have shown that ancestral human diets, so called "paleo" diets, did not necessarily result in better appetite suppression.
Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
Provectus holds second meeting with Australian TGA to review approval of PV-10 for metastatic melanoma
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
› Verified 7 days ago